Gene Therapy for Fanconi Anemia, Complementation Group A
Clinical trial NCT04248439 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04248439
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2026-05-05
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.